Michael John Parnham received his BSc (Hons) in Pharmacology (1973) from the University of London, a PhD in Pharmacology from Bristol University, UK (1976) and Habilitation from Goethe University, Frankfurt/Main, Germany (1990). He is currently Senior Advisor to EpiEndo Pharmaceuticals, Iceland, Research Advisor to Phialogics, Switzerland and Professor of Pharmacology and Toxicology at Goethe University Frankfurt. Previously, he held research management positions at Fraunhofer Institute, GSK, PLIVA, Rhone-Poulenc and Nattermann. He has over 350 publications, including books, in the fields of inflammation, immunopharmacology, respiratory disorders and pain, is a fellow of several societies (FRSB, FBPhS) and recipient of a Lifetime Achievement Award (IAIS, 2015). His current research interests are in the therapy of respiratory inflammation and in the immunoregulation of autoimmunity.